Physician

Aniruddha Venkatesh Palya, MD, MPH

According to 2025 Medicare claims, Aniruddha Palya, MD, MPH (NPI: 1346485513) practices nephrology in the Flint, MI market, with the plurality of this provider's patient population coming from Genesee, MI. This provider's primary affiliated billing organization is KIDNEY DISEASE & HYPERTENSION CONSULTANTS PC (NPI: 1548329683; TIN: 20-5917382) and primary practice location at 48602-4727. Palya is affiliated with the POM ACO (ACO ID: A1297), McLaren High Performance Network, LLC (ACO ID: A3317), and Mosaic ACO (ACO ID: A5033), participating under the MSSP model.

Palya's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 530 traditional Medicare patients, billed 1,815 HCPCS/CPT codes, and received $172,139 in Medicare payments. The top billing code was 90961 (Dialysis services, 2-3 physician visits per month (20 years or older)). Part D data shows 4,484 prescription claims across 715 beneficiaries totaling $1,003,191 in drug costs, led by Mounjaro (Tirzepatide). 2023 DME data shows 215 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $368,605 to $172,139. In contrast, Part D prescription costs have moved sharply higher in recent years, from $654,267 to $1,003,191. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$184K$369K2015 Medicare payment: $368,605 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $337,976 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $328,390 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $308,819 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $339,647 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $309,408 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $327,285 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $259,023 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $227,977 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $172,139 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0684,061$368,605
20161,0423,886$337,976
20179633,714$328,390
20188953,337$308,819
20198283,598$339,647
20207613,169$309,408
20218263,381$327,285
20227352,814$259,023
20236502,377$227,977
20245301,815$172,139

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$502K$1.0M2015 Drug cost: $654,267 (USD; Tot_Drug_Cst)2016 Drug cost: $627,093 (USD; Tot_Drug_Cst)2017 Drug cost: $725,693 (USD; Tot_Drug_Cst)2018 Drug cost: $440,763 (USD; Tot_Drug_Cst)2019 Drug cost: $286,171 (USD; Tot_Drug_Cst)2020 Drug cost: $272,145 (USD; Tot_Drug_Cst)2021 Drug cost: $342,318 (USD; Tot_Drug_Cst)2022 Drug cost: $499,623 (USD; Tot_Drug_Cst)2023 Drug cost: $937,903 (USD; Tot_Drug_Cst)2024 Drug cost: $1,003,191 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154512,656$654,267
20165043,204$627,093
20174893,523$725,693
20185303,234$440,763
20195493,232$286,171
20205253,233$272,145
20216504,183$342,318
20227314,498$499,623
20237875,207$937,903
20247154,484$1,003,191

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$41K$82K2015 Medicare payment: $14,009 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $9,552 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $7,930 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $4,483 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $10,193 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $176 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $81,686 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R167$14,009
2016N/R183$9,552
2017N/R220$7,930
2018N/R153$4,483
2019N/R112$10,193
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R14$176
2023N/R215$81,686
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
90961Dialysis services, 2-3 physician visits per month (20 years or older)2984$226
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes9398$130
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes4453$100
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes251939$60
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more218325$42

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MounjaroTirzepatide1575,186$184,506
OzempicSemaglutide1615,968$174,821
JardianceEmpagliflozin744,228$79,911
FarxigaDapagliflozin Propanediol743,181$58,172
TrulicityDulaglutide451,710$56,340

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Aniruddha Venkatesh Palya, MD, MPH?

Tedicare shows public-source Medicare data for Aniruddha Venkatesh Palya, MD, MPH (NPI 1346485513), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aniruddha Venkatesh Palya, MD, MPH have ACO affiliation data?

Aniruddha Venkatesh Palya, MD, MPH is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297), McLaren High Performance Network, LLC (MSSP, ACO ID A3317), and Mosaic ACO (MSSP, ACO ID A5033).

What billing organization is linked to Aniruddha Venkatesh Palya, MD, MPH?

Aniruddha Venkatesh Palya, MD, MPH is linked to KIDNEY DISEASE & HYPERTENSION CONSULTANTS PC (billing NPI 1548329683) in the available physician profile data.

Does Aniruddha Venkatesh Palya, MD, MPH have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.